TargImmune Therapeutics’ CHF 17.7 Million Financing Round

Federica Tiefenthaler Europe, Europe Legal Chronicle
Tagged:

VISCHER has advised TargImmune on the deal.TargImmune Therapeutics has closed its 2021 financing round, raising CHF 17.7m. TargImmune is a private Swiss-based biotechnology firm focused on…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Federica Tiefenthaler

Author: Federica Tiefenthaler

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here